Is it wise to target the late costimulatory molecule OX40 as a therapeutic target? Mary Miranda CavanaghTracy Hussell REVIEW 06 October 2008 Pages: 291 - 297
Opiate abuse, innate immunity, and bacterial infectious diseases Jinghua WangRoderick A. BarkeSabita Roy REVIEW 06 October 2008 Pages: 299 - 309
Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer Sheela RamanathanJulien GagnonSubburaj Ilangumaran REVIEW 06 October 2008 Pages: 311 - 323
Mesenchymal stromal cells: tissue engineers and immune response modulators Lieke C. J. van den BerkCarl G. FigdorRuurd Torensma REVIEW 06 October 2008 Pages: 325 - 329
Structure and physiological functions of the human peroxisome proliferator-activated receptor γ Andrzej ZieleniakMarzena WójcikLucyna A. Woźniak REVIEW 06 October 2008 Pages: 331 - 345
Immunochemical studies of the lipopolysaccharides of Hafnia alvei PCM 1219 and other strains with the O-antigens containing D-glucose 1-phosphate and 2-deoxy-2-[(R)-3-hydroxybutyramido]-D-glucose Ewa KatzenellenbogenNina A. KocharovaYuriy A. Knirel ORIGINAL ARTICLE Open access 06 October 2008 Pages: 347 - 352